Adjuvant Medroxyprogesterone Acetate to Radical Nephrectomy in Renal Cancer: 5-Year Results of a Prospective Randomized Study-Reference-Cited by-同舟云学术

Adjuvant Medroxyprogesterone Acetate to Radical Nephrectomy in Renal Cancer: 5-Year Results of a Prospective Randomized Study

Published:1987-12 Issue:6 Volume:138 Page:1379-1381
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Pizzocaro Giorgio¹²³,Piva Luigi¹²³,Fronzo Giovanni Di¹²³,Giongo Augusto¹²³,Cozzoli Alberto¹²³,Dormia Enrico¹²³,Minervini Silvano¹²³,Zanollo Alberto¹²³,Fontanella Umberto¹²³,Longo Giovanni¹²³,Maggioni Augusto¹²³

Affiliation:

1. From the Section of Urologic Oncology and Department of Experimental Oncology C, Istituto Nazionale Tumori, Milano

2. Departments of Urology, Spedali Civili, Brescia, Distric Hospital, Lecco

3. Distric Hospital, Magenta and University Medical School, Milano, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference10 articles.

1. Current status of the therapy of advanced renal carcinoma;Hrushesky;J. Surg. Oncol.,1977

2. Renal cancer steroid receptors: biochemical basis for endocrine therapy;Concolino;Eur. Urol.,1979

3. Attuali orientamenti nella diagnosie terapia dei carcinomi del rene. L’ormonodipendenza;Bracci;AttiXLIX Congresso Soc. Ital. Urol.,1976

4. Progestogens in renal cell carcinoma. A retrospective study;Bono;Eur. Urol,1979

5. Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial;Pizzocaro;Eur. Urol,1983

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Therapy vs Surveillance in Patients with Resected Early-Stage Intermediate to High-Risk Renal Cell Carcinoma;Kidney Cancer;2023-05-26

2. The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer;Urologic Clinics of North America;2023-05

3. Management of Renal Cell Carcinoma with IVC Thrombus, Nodal Involvement, and T4 Disease;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to Date

;OncoTargets and Therapy;2020-11

5. The Role of Targeted Therapy in the Management of High-Risk Resected Kidney Cancer;The Cancer Journal;2020-09